Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582881 · ClinicalTrials.gov registry record
Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 124
- Enrollment target
NCT00582881 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 124 participants.
The verdict
NCT00582881 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are long-term autoimmune diseases in which the immune system attacks parts of the body. The abnormal immune reaction causes inflammation of and damage to various body parts and can affect joints, skin, kidneys, heart, lungs, blood vessels, and the brain. SLE and MCTD often affect young women, especially black and Hispanic women, and there is no known cure. Knowing more about SLE and MCTD will help in developing new and effective treatments. The purpose of this study is to characterize immune system abnormalities, genetic components, and disease progression in people with SLE and MCTD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2007-10 |
| Est. Completion | 2025-06-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582881
The ClinicalTrials.gov registry entry for NCT00582881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00582881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582881 about?
NCT00582881 is a clinical study titled "Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus". Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are long-term autoimmune diseases in which the immune system attacks parts of the body. The abnormal immune reaction causes inflammation of and damage to various body parts and can affect joints, skin, kidneys, heart, lung...
What is the current status of trial NCT00582881?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2007-10. Estimated completion is 2025-06-27.
Who is sponsoring clinical trial NCT00582881?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.